Captrust Financial Advisors Chemo Centryx, Inc. Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

Shares

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 23, 2022	SELL	$15.36 - $27.51 $2,288 - $4,098	-149 Reduced 3.71%	3,866 $96,000
Q2 2022 Aug 16, 2022	BUY	$15.36 - $27.51 $42,439 - $76,010	2,763 Added 220.69%	4,015 $99,000
Q1 2022 May 16, 2022	SELL	$22.22 - $39.12 $58,927 - $103,746	-2,652 Reduced 67.93%	1,252 $31,000
Q4 2021 Feb 14, 2022	BUY	$18.38 - $40.5 $7,076 - $15,592	385 Added 10.94%	3,904 $142,000
Q3 2021 Nov 16, 2021	BUY	$13.18 - $19.83 $2,306 - $3,470	175 Added 5.23%	3,519 $60,000
Q2 2021 Aug 16, 2021	BUY	$9.59 - $50.88 $2,675 - $14,195	279 Added 9.1%	3,344 $45,000
Q1 2021 May 17, 2021	BUY	$49.53 - $68.4 $742 - $1,026	15 Added 0.49%	3,065 $157,000
Q4 2020 Feb 16, 2021	BUY	$47.25 - $65.16 $132,300 - $182,448	2,800 Added 1120.0%	3,050 $189,000
Q3 2020 Nov 17, 2020	SELL	$46.35 - $61.69 $129,780 - $172,732	-2,800 Reduced 91.8%	250 $14,000
Q2 2020 Aug 14, 2020	SELL	$38.58 - $65.07 $15,432 - $26,027	-400 Reduced 11.59%	3,050 $177,000
Q1 2020 May 15, 2020	BUY	$32.73 - $50.78 $112,918 - $175,191	3,450 New	3,450 $133,000
Q4 2019 Feb 14, 2020	SELL	$6.81 - $39.55 $27,240 - $158,200	-4,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$6.47 - $8.96 $12,940 - $17,920	2,000 Added 100.0%	4,000 $27,000
Q2 2019 Aug 13, 2019	BUY	$8.31 - $14.85 $16,620 - $29,700	2,000 New	2,000 $19,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.